FY26 UDO initiative - custom conditional gpnmb cdna cassette knockin mouse model

Ended Purchase Order Awarded Last action

Contract number
75N95024P00501
Awardee
Awarding agency
Obligated
$25,098

Award facts

Opportunity
Contract value 100% obligated
$25,098.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute on Aging National Institutes of Health, Department of Health and Human Services
NAICS code
115210 Support Activities for Animal Production
PSC
R416 Support- Professional: Veterinary/Animal Care
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lake Ronkonkoma, NY 11779, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute on Aging has awarded a $25,098 firm fixed-price purchase order to Ingenious Targeting Laboratory Inc., a minority-owned small disadvantaged business located in Ronkonkoma, New York, for the development of a custom conditional GPNMB cDNA cassette knockin mouse model. This non-competitive, single-source acquisition was conducted under simplified acquisition procedures with an anticipated performance period of 9–11 months and no set-aside designation. The deliverable is a Cre-inducible GPNMB-diphtheria toxin receptor knockin mouse designed to facilitate research into the role of GPNMB-positive macrophages in skeletal muscle injury response and aging—a critical focus area for the National Institute on Aging's biomedical research mission.

Ingenious Targeting Laboratory Inc. brings substantial expertise to this engagement, having demonstrated consistent capability in delivering specialized gene targeting and custom mouse model services to multiple federal health agencies. The company maintains active IACUC approval, AAALAC accreditation, and compliance with Public Health Service Policy on humane care and use of laboratory animals, meeting all regulatory requirements for this procurement. The contractor's track record includes prior contract awards from the National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, and Veterans Health Administration, as well as a significant research grant from the National Institute of Allergy and Infectious Diseases focused on humanized mouse model development, positioning the company as a qualified provider of advanced genetic research animal models for federal biomedical research initiatives.

Quick answers

Who was awarded contract 75N95024P00501?

75N95024P00501 was awarded to Ingenious Targeting Laboratory Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 26, 2024.

How much is contract 75N95024P00501 worth?

The government has obligated $25,098 on 75N95024P00501.

Which agency awarded contract 75N95024P00501?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00501, with funding from National Institute on Aging (National Institutes of Health).

Was contract 75N95024P00501 competed?

The extent of competition for 75N95024P00501 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award